Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Cerus
(NASDAQ:CERS)
Intraday
$1.71
0.01
[0.59%]
After-Hours
$1.71
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$1.71
0.01
[0.59%]
At close: Apr 26
$1.71
0
[0.00%]
After Hours: 4:20PM EDT
Get Report
Watch
Q1 2024 Earnings in 6 days from now on Thu May 2nd, after the market close
Conference call scheduled in 6 days at 16:30 PM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Cerus Stock (NASDAQ:CERS)
Cerus Stock (NASDAQ: CERS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 12, 2024
Craig-Hallum Initiates Coverage On Cerus with Buy Rating, Announces Price Target of $5
Benzinga Newsdesk
-
Apr 12, 2024, 8:07AM
Monday, April 08, 2024
Perion Network Cuts Sales Outlook, Joins Range Resources And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
-
Apr 8, 2024, 8:24AM
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Apr 5, 2024, 4:31PM
Tuesday, March 26, 2024
Cerus Corporation Announces FDA Approval Of Extended Shelf Life For INTERCEPT Platelet Processing Sets, Doubling Previous Shelf Life
Benzinga Newsdesk
-
Mar 26, 2024, 8:31AM
Wednesday, March 20, 2024
Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
Benzinga Neuro
-
Mar 20, 2024, 11:40PM
Tuesday, March 19, 2024
Why Blood Components-Focused Cerus Stock Is Rising Tuesday
Vandana Singh
-
Mar 19, 2024, 2:39PM
Cerus Corporation shares are trading higher after the company announced its ReCePI Phase 3 trial of INTERCEPT Blood System met its primary efficacy endpoint.
Benzinga Newsdesk
-
Mar 19, 2024, 9:05AM
Market-Moving News for March 19th
Benzinga Newsdesk
-
Mar 19, 2024, 8:41AM
Cerus Corporation Shares Resume Trade, Shares Spike Higher
Benzinga Newsdesk
-
Mar 19, 2024, 8:33AM
Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times
Benzinga Newsdesk
-
Mar 19, 2024, 8:25AM
Cerus Corporation Announces Its ReCePI Phase 3 Trial Of INTERCEPT Blood System Met Its Primary Efficacy Endpoint; Safety Endpoint Of The Proportion Of Patients With Any Related Treatment-Emergent Adverse Events Within 28 Days Of Last Transfusion Was Not Significantly Different For Intercept RBCs
Benzinga Newsdesk
-
Mar 19, 2024, 8:03AM
Trading Halt: Halted at 7:55:00 a.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk
-
Mar 19, 2024, 7:55AM
Wednesday, March 13, 2024
Cathie Wood's Ark Invest Sells Coinbase Shares As Bitcoin Hits Yet Another All-Time New High, Buys Stock Of This Social Media Company
Benzinga Neuro
-
Mar 13, 2024, 11:41PM
Thursday, March 07, 2024
Stephens & Co. Reiterates Equal-Weight on Cerus, Maintains $2.5 Price Target
Benzinga Newsdesk
-
Mar 7, 2024, 10:32AM
Wednesday, March 06, 2024
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Mar 6, 2024, 1:54PM
Cantor Fitzgerald Reiterates Overweight on Cerus, Maintains $3 Price Target
Benzinga Newsdesk
-
Mar 6, 2024, 12:29PM
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Mar 6, 2024, 11:45AM
Cerus shares are trading higher after the company reported better-than-expected Q4 GAAP EPS results.
Benzinga Newsdesk
-
Mar 6, 2024, 10:51AM
Tuesday, March 05, 2024
Cerus Sees FY24 Revenue $172M-$175M Vs $185.871M Est.
Benzinga Newsdesk
-
Mar 5, 2024, 4:42PM
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Mar 5, 2024, 4:31PM
Cerus: Q4 Earnings Insights
Benzinga Insights
-
Mar 5, 2024, 4:20PM
Cerus Q4 2023 GAAP EPS $(0.010) Beats $(0.020) Estimate, Sales $46.768M Miss $49.267M Estimate
Benzinga Newsdesk
-
Mar 5, 2024, 4:19PM
Earnings Scheduled For March 5, 2024
Benzinga Insights
-
Mar 5, 2024, 5:00AM
Monday, March 04, 2024
Cerus's Earnings: A Preview
Benzinga Insights
-
Mar 4, 2024, 10:02AM
Tuesday, February 06, 2024
GE HealthCare Technologies Posts Upbeat Earnings, Joins Toyota, Spotify And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
-
Feb 6, 2024, 10:20AM
Monday, January 08, 2024
Cerus Corporation Sees Prelim. Q4 Product Revenues $46.8M And FY23 Product Revenues $156.4M; 2024 Product Revenues Expected To Be $172M-$175M
Benzinga Newsdesk
-
Jan 8, 2024, 8:56AM
Wednesday, November 08, 2023
Cantor Fitzgerald Assumes Cerus at Overweight, Lowers Price Target of $3
Benzinga Newsdesk
-
Nov 8, 2023, 12:12PM
Monday, November 06, 2023
Cerus shares are trading lower amid a significant increase in price last week.
Luke J Jacobi
-
Nov 6, 2023, 8:27AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Nov 6, 2023, 8:06AM
Friday, November 03, 2023
Shares of healthcare equipment and healthcare provider stocks are trading higher amid overall market strength. Strength may also be attributed to Cardinal Health after the company reported better-than-expected Q1 financial results.
Benzinga Newsdesk
-
Nov 3, 2023, 3:33PM
Thursday, November 02, 2023
Cerus Corporation Sees FY23 Revenue $155M-$158M Vs $167.7M Est.
Benzinga Newsdesk
-
Nov 2, 2023, 5:47PM
Cerus Q3 2023 EPS $(0.04) Beats $(0.05) Estimate, Sales $39.77M Miss $42.50M Estimate
Benzinga Newsdesk
-
Nov 2, 2023, 4:02PM
Earnings Scheduled For November 2, 2023
Benzinga Insights
-
Nov 2, 2023, 4:56AM
Wednesday, November 01, 2023
Bloodbuy Announces Agreement With Cerus Corporation To Offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex On Its Digital Marketplace
Benzinga Newsdesk
-
Nov 1, 2023, 2:53PM
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 19, 2023, 12:50PM
Friday, September 08, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 8, 2023, 1:58PM
Thursday, August 03, 2023
Cerus Corporation shares are trading lower after the company reported worse-than-expected Q2 financial results and issued FY23 annual product revenue guidance.
Benzinga Newsdesk
-
Aug 3, 2023, 1:28PM
Wednesday, August 02, 2023
Cerus Sees FY23 Annual Product Revenue $160M-$165M
Benzinga Newsdesk
-
Aug 2, 2023, 5:04PM
Cerus Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $38.85M Miss $40.80M Estimate
Benzinga Newsdesk
-
Aug 2, 2023, 4:01PM
Earnings Scheduled For August 2, 2023
Benzinga Insights
-
Aug 2, 2023, 8:45AM
Monday, June 05, 2023
Cerus Corporation Announces Follow-On Award Of $8.7M Amendment To Original $9.1M Contract By U.S. DOD For Development Of Pathogen Reduced, Lyophilized Cryoprecipitate
Benzinga Newsdesk
-
Jun 5, 2023, 8:34AM
Thursday, May 18, 2023
Cerus Earnings Perspective: Return On Capital Employed
Benzinga Insights
-
May 18, 2023, 10:46AM
Friday, May 12, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
May 12, 2023, 1:08PM
Thursday, May 11, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
May 11, 2023, 1:47PM
Friday, May 05, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
May 5, 2023, 1:54PM
Thursday, May 04, 2023
Recap: Cerus Q1 Earnings
Benzinga Insights
-
May 4, 2023, 5:16PM
Cerus Reiterates FY23 Revenue Guidance $165M - $170M
Benzinga Newsdesk
-
May 4, 2023, 4:04PM
Cerus Q1 EPS $(0.09) Misses $(0.07) Estimate, Sales $30.97M Miss $34.83M Estimate
Benzinga Newsdesk
-
May 4, 2023, 4:01PM
Earnings Scheduled For May 4, 2023
Benzinga Insights
-
May 4, 2023, 6:34AM
Friday, April 28, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Apr 28, 2023, 1:49PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch